Related Experiment Videos
Maintenance requirement of alcuronium in paediatric patients
1Department of Anaesthesia, Royal Children's Hospital, Victoria.
Insights
Alcuronium effectively maintains neuromuscular block in paediatric patients during anesthesia. Its maintenance dose requirement is consistent across infants, children, and adolescents, ensuring similar effects in all pediatric age groups.
Area of Science:
- Anesthesiology
- Pharmacology
- Pediatric Medicine
Background:
- Neuromuscular blocking agents are crucial in pediatric anesthesia.
- Alcuronium's specific dose-response and maintenance needs in children require detailed investigation.
Purpose of the Study:
- To determine alcuronium dose-response curves in pediatric patients.
- To establish alcuronium maintenance requirements during nitrous oxide-oxygen-opioid anesthesia.
- To compare alcuronium's effects across different pediatric age groups.
Main Methods:
- Seventeen pediatric patients (0.3-19 years) were studied.
- Individual dose-response curves and maintenance requirements were assessed.
- Neuromuscular block was monitored during anesthesia.
Main Results:
- A dose of 300 µg/kg alcuronium maintained 90-95% neuromuscular block for an average of 62 minutes.
- The duration was significantly longer in patients under 1 year (92 minutes).
- The hourly maintenance requirement was 0.41 (0.12) times the ED95 dose, consistent across age groups.
Conclusions:
- Alcuronium demonstrates predictable neuromuscular blockade in pediatric patients.
- Maintenance requirements are similar across infants, children, and adolescents.
- Alcuronium provides a consistent duration of effect in pediatric populations.
Abstract:
Seventeen paediatric patients from 0.3 to 19 years old were studied to determine the individual dose-response curves and the maintenance requirements of alcuronium during N2O-O2-opioid anaesthesia. Alcuronium 300 micrograms/kg maintained the mean (SD) neuromuscular block at 90-95% for 62 34 min). This time was longest in patients of less than 1 year of age (92 min). The hourly maintenance requirement of alcuronium was 0.41 (0.12) times the individual ED95 dose. This value was comparable in infants, children and adolescents and indicates similar duration of effect of alcuronium in all paediatric age groups.